Evan Kiel

Evan Kiel is an experienced professional in clinical development, currently serving as Manager of Clinical Development at UroGen Pharma since November 2020, where responsibilities include managing study operational plans, project timelines, and trial budgets. Prior to this role, Evan worked at PRA Health Sciences from August 2016 to November 2020 as In House CRA III and then In House CRA II on assignment at Sanofi, focusing on trial conduct, quality control of clinical documentation, and vendor management. Evan's career began at CR Bard as a Clinical Trial Associate, followed by a role as Regulatory Affairs Coordinator at Celerion, and includes experience as a Certified Pharmacy Technician. Evan holds a Bachelor of Science in Communication Studies from Drexel University and an Associate of Arts in Education from Brookdale Community College.